I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

INBX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.20%

Insider Buying (Last 12 Months): $3,618,717.42

Insider Selling (Last 12 Months): $10,290,000.00

Inhibrx Insider Trading History Chart

Inhibrx Share Price & Price History

^$14.60

▲ +0.72 (5.19%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Inhibrx Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/19/2024	Jon Faiz Kayyem	Director	Buy	69,686	$14.23	$991,631.78	51,093
9/16/2024	Mark Lappe	CEO	Buy	13,037	$17.13	$223,323.81	705,548
9/12/2024	Mark Lappe	CEO	Buy	26,963	$15.05	$405,793.15	692,511
9/10/2024	Kristiina Md Vuori	Director	Buy	179	$15.00	$2,685.00	7,319
9/9/2024	Mark Lappe	CEO	Buy	9,500	$15.21	$144,495.00	657,048
9/6/2024	Mark Lappe	CEO	Buy	26,000	$15.29	$397,540.00	647,548
9/3/2024	Mark Lappe	CEO	Buy	20,000	$15.81	$316,200.00	165,000
8/29/2024	Mark Lappe	CEO	Buy	10,000	$14.03	$140,300.00	135,000
6/5/2024	Jon Faiz Kayyem	Director	Buy	57,549	$17.32	$996,748.68	1,150,410
5/28/2024	Brendan P. Eckelman	Insider	Sell	300,000	$34.30	$10,290,000.00	1,735,553
8/28/2023	Global Investors Lp Viking	Major Shareholder	Buy	511,627	$19.35	$9,899,982.45	511,627
2/1/2023	Brendan P. Eckelman	Insider	Sell	28,750	$24.73	$710,987.50	2,086,803
1/23/2023	Jon Faiz Kayyem	Director	Sell	9,500	$25.26	$239,970.00	3,224,301
1/23/2023	Mark Lappe	CEO	Sell	21,665	$25.36	$549,424.40	2,490,587
1/3/2023	Brendan P. Eckelman	Insider	Sell	32,895	$23.77	$781,914.15	2,122,658
12/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$27.02	$256,690.00	3,233,801
12/19/2022	Mark Lappe	CEO	Sell	26,000	$25.56	$664,560.00	2,512,252
12/6/2022	Brendan P. Eckelman	Insider	Sell	40,000	$27.22	$1,088,800.00	2,155,553
11/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$29.89	$283,955.00	3,243,301
11/1/2022	Brendan P. Eckelman	Insider	Sell	40,000	$33.51	$1,340,400.00	2,195,553
10/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$30.13	$286,235.00	3,252,801
10/17/2022	Mark Lappe	CEO	Sell	26,000	$29.59	$769,340.00	2,564,252
10/7/2022	Global Investors Lp Viking	Major Shareholder	Buy	1,333,333	$30.00	$39,999,990.00	2,427,307
10/4/2022	Brendan P. Eckelman	Insider	Sell	40,000	$27.82	$1,112,800.00	2,235,553
8/2/2022	Brendan P. Eckelman	Insider	Sell	24,500	$17.70	$433,650.00	2,491,053
7/7/2022	Brendan P. Eckelman	Insider	Sell	40,000	$17.17	$686,800.00	2,515,553
4/5/2022	Brendan P. Eckelman	Insider	Sell	400	$25.04	$10,016.00

Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

From Weiss Ratings | Ad

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

SEC Filings (Institutional Ownership Changes) for Inhibrx (NASDAQ:INBX)

82.46% of Inhibrx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Inhibrx Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/17/2024	RA Capital Management L.P.	2,629,837	$91.94M	1.2%	-44.3%	5.019%
5/16/2024	California State Teachers Retirement System	22,593	$0.79M	0.0%	-2.4%	0.043%
5/16/2024	Black Maple Capital Management LP	15,863	$0.56M	0.3%	N/A	0.030%
5/15/2024	Price T Rowe Associates Inc. MD	14,812	$0.52M	0.0%	+8.1%	0.028%
5/15/2024	Alpine Global Management LLC	35,000	$1.22M	0.3%	N/A	0.067%
5/14/2024	Platinum Investment Management Ltd.	145,966	$5.10M	0.2%	-13.0%	0.279%
5/10/2024	Vanguard Group Inc.	1,861,469	$65.08M	0.0%	-0.7%	3.561%
5/10/2024	MMCAP International Inc. SPC	451,433	$15.78M	2.1%	N/A	0.863%
5/8/2024	Entropy Technologies LP	10,982	$0.38M	0.0%	N/A	0.021%
5/8/2024	ProShare Advisors LLC	16,741	$0.59M	0.0%	+92.2%	0.032%
5/8/2024	Russell Investments Group Ltd.	190,389	$6.66M	0.0%	-56.3%	0.364%
5/7/2024	Swiss National Bank	42,000	$1.47M	0.0%	+8.5%	0.080%
5/2/2024	FORA Capital LLC	16,103	$0.56M	0.0%	N/A	0.031%
5/2/2024	Fifth Lane Capital LP	10,200	$0.36M	0.3%	N/A	0.020%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	21,920	$0.77M	0.0%	+7.0%	0.042%
4/29/2024	China Universal Asset Management Co. Ltd.	9,106	$0.32M	0.0%	+66.4%	0.017%
4/17/2024	Hennion & Walsh Asset Management Inc.	30,561	$1.07M	0.1%	+2.5%	0.064%
3/5/2024	Wellington Management Group LLP	145,398	$5.53M	0.0%	-16.9%	0.307%
2/20/2024	Readystate Asset Management LP	13,839	$0.53M	0.0%	N/A	0.029%
2/15/2024	PFM Health Sciences LP	537,964	$20.44M	1.2%	+86.4%	1.138%
2/15/2024	Birchview Capital LP	48,448	$1.84M	1.5%	-31.2%	0.102%
2/14/2024	Bellevue Group AG	24,600	$0.94M	0.0%	-49.6%	0.052%
2/14/2024	Platinum Investment Management Ltd.	167,763	$6.38M	0.3%	-26.8%	0.355%
2/14/2024	Vestal Point Capital LP	1,530,000	$58.14M	6.2%	N/A	3.235%
2/13/2024	Capital Research Global Investors	712,360	$27.07M	0.0%	-41.7%	1.506%
2/13/2024	Rafferty Asset Management LLC	103,246	$3.92M	0.0%	-10.9%	0.218%
2/13/2024	Campbell & CO Investment Adviser LLC	23,516	$0.89M	0.1%	N/A	0.050%
2/9/2024	HCR Wealth Advisors	6,300	$0.24M	0.0%	N/A	0.013%
2/8/2024	Quadrant Capital Group LLC	690	$26K	0.0%	N/A	0.001%
2/7/2024	Principal Financial Group Inc.	10,368	$0.39M	0.0%	-3.7%	0.022%
2/7/2024	E Fund Management Co. Ltd.	5,512	$0.21M	0.0%	N/A	0.012%
2/6/2024	Charles Schwab Investment Management Inc.	229,866	$8.74M	0.0%	+8.4%	0.486%
2/6/2024	AJOVista LLC	678	$26K	0.0%	N/A	0.001%
2/6/2024	M&T Bank Corp	23,843	$0.91M	0.0%	-16.4%	0.050%
2/6/2024	Amalgamated Bank	4,250	$0.16M	0.0%	-7.6%	0.009%
2/6/2024	Swiss National Bank	38,700	$1.47M	0.0%	-32.8%	0.082%
2/5/2024	Russell Investments Group Ltd.	435,450	$16.55M	0.0%	-5.1%	0.921%
2/1/2024	Signaturefd LLC	758	$29K	0.0%	+4,637.5%	0.002%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	20,494	$0.78M	0.0%	+6.9%	0.043%
1/24/2024	Arizona State Retirement System	5,494	$0.21M	0.0%	N/A	0.012%
1/24/2024	China Universal Asset Management Co. Ltd.	5,471	$0.21M	0.0%	+389.8%	0.012%
1/5/2024	Exchange Traded Concepts LLC	6,705	$0.26M	0.0%	+34.0%	0.014%
12/18/2023	Vanguard Group Inc.	1,789,811	$32.84M	0.0%	+1.0%	3.785%
12/6/2023	Citigroup Inc.	49,244	$0.90M	0.0%	+3.4%	0.104%
12/1/2023	Wellington Management Group LLP	174,899	$3.21M	0.0%	+24.4%	0.370%
11/15/2023	RA Capital Management L.P.	4,724,207	$86.69M	1.7%	+22.6%	9.990%
11/14/2023	Eventide Asset Management LLC	434,026	$7.96M	0.1%	N/A	0.994%
11/14/2023	Profund Advisors LLC	19,746	$0.36M	0.0%	-18.3%	0.045%
11/13/2023	FMR LLC	1,517,595	$27.85M	0.0%	-14.3%	3.475%
11/13/2023	Rafferty Asset Management LLC	115,828	$2.13M	0.0%	-12.4%	0.265%
11/9/2023	Loomis Sayles & Co. L P	1,116,484	$20.49M	0.0%	-3.0%	2.557%
11/9/2023	Citigroup Inc.	49,244	$0.90M	0.0%	+3.4%	0.113%
11/8/2023	Charles Schwab Investment Management Inc.	212,104	$3.89M	0.0%	-13.8%	0.486%
11/8/2023	Swiss National Bank	57,600	$1.06M	0.0%	+2.1%	0.132%
11/7/2023	Barclays PLC	63,177	$1.15M	0.0%	-7.8%	0.145%
11/7/2023	Fox Run Management L.L.C.	12,621	$0.23M	0.1%	N/A	0.029%
10/27/2023	Hennion & Walsh Asset Management Inc.	27,731	$0.51M	0.0%	+89.5%	0.064%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	19,163	$0.35M	0.0%	-3.8%	0.044%
10/24/2023	Bank of New York Mellon Corp	114,388	$2.10M	0.0%	-0.8%	0.262%
8/24/2023	Perceptive Advisors LLC	3,624,182	$94.08M	2.7%	+0.2%	8.299%
8/15/2023	Sphera Funds Management LTD.	50,000	$1.30M	0.2%	N/A	0.114%
8/14/2023	ArrowMark Colorado Holdings LLC	958,880	$24.89M	0.3%	+1.9%	2.196%
8/14/2023	Bellevue Group AG	48,800	$1.27M	0.0%	+64.3%	0.112%
8/11/2023	Natixis	45,000	$1.17M	0.0%	N/A	0.103%
8/11/2023	Velan Capital Investment Management LP	25,000	$0.65M	0.6%	N/A	0.057%
8/11/2023	Platinum Investment Management Ltd.	229,036	$5.95M	0.2%	+3.1%	0.524%
8/10/2023	Profund Advisors LLC	24,155	$0.63M	0.0%	-16.1%	0.055%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	19,918	$0.52M	0.0%	-6.7%	0.046%
8/10/2023	Russell Investments Group Ltd.	425,541	$11.05M	0.0%	+33.6%	0.976%
8/10/2023	Citigroup Inc.	47,633	$1.24M	0.0%	-61.7%	0.109%
8/9/2023	RS Crum Inc.	14,659	$0.38M	0.1%	N/A	0.034%
8/7/2023	Principal Financial Group Inc.	10,343	$0.27M	0.0%	N/A	0.024%
8/4/2023	American International Group Inc.	16,530	$0.43M	0.0%	+5.1%	0.038%
8/3/2023	Bank of New York Mellon Corp	115,296	$2.99M	0.0%	+9.4%	0.264%
7/20/2023	Exchange Traded Concepts LLC	5,165	$0.13M	0.0%	N/A	0.012%
5/12/2023	Profund Advisors LLC	28,799	$0.54M	0.0%	N/A	0.066%
5/12/2023	Platinum Investment Management Ltd.	222,209	$4.19M	0.1%	+38.8%	0.509%
5/11/2023	M&T Bank Corp	21,804	$0.41M	0.0%	+22.4%	0.050%
5/11/2023	Citigroup Inc.	124,335	$2.35M	0.0%	+43.7%	0.285%
5/9/2023	Tower Research Capital LLC TRC	6,348	$0.12M	0.0%	+28.6%	0.015%
5/9/2023	California State Teachers Retirement System	35,068	$0.66M	0.0%	+5.1%	0.080%
5/9/2023	Russell Investments Group Ltd.	318,505	$6.01M	0.0%	-0.3%	0.731%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	3,059	$58K	0.0%	-15.4%	0.007%
5/4/2023	Barclays PLC	64,661	$1.19M	0.0%	-39.3%	0.148%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	21,356	$0.40M	0.0%	+46.0%	0.049%
5/4/2023	Los Angeles Capital Management LLC	30,823	$0.58M	0.0%	-25.5%	0.071%
5/3/2023	Jump Financial LLC	25,509	$0.48M	0.0%	-23.0%	0.059%
5/2/2023	Amalgamated Bank	4,604	$87K	0.0%	-15.6%	0.011%
5/1/2023	Virtu Financial LLC	10,369	$0.20M	0.0%	N/A	0.024%
4/28/2023	SG Americas Securities LLC	15,163	$0.29M	0.0%	+249.5%	0.035%
3/23/2023	MetLife Investment Management LLC	17,746	$0.44M	0.0%	+3.0%	0.041%
2/15/2023	Endurant Capital Management LP	13,485	$0.33M	0.1%	N/A	0.031%
2/14/2023	RA Capital Management L.P.	3,853,867	$94.96M	1.9%	N/A	8.849%
2/14/2023	Pura Vida Investments LLC	93,575	$2.31M	0.1%	N/A	0.215%
2/13/2023	Platinum Investment Management Ltd.	160,127	$3.95M	0.2%	+9.5%	0.368%
2/13/2023	Gyon Technologies Capital Management LP	44,074	$1.09M	0.4%	N/A	0.101%
2/13/2023	GSA Capital Partners LLP	19,068	$0.47M	0.1%	N/A	0.044%
2/13/2023	M&T Bank Corp	28,965	$2.18M	0.0%	+7.0%	0.067%
2/10/2023	New York Life Investment Management LLC	25,458	$0.63M	0.0%	+12.7%	0.058%
2/10/2023	Schroder Investment Management Group	375,075	$9.24M	0.0%	-19.2%	0.861%

Data available starting January 2016

Inhibrx, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidate includes INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also develops INBRX-109, a tetravalent therapeutic candidate targeting death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, colorectal cancer, ewing sarcoma, and pancreatic adenocarcinoma; and INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company has license and collaboration agreements with 2seventy bio, Inc. and Bristol-Myers Squibb Company. Inhibrx, Inc. was incorporated in 2009 and is headquartered in La Jolla, California.

Today's Range

Now: $14.60

$13.51

$14.72

50 Day Range

MA: $15.25

$13.62

$16.58

52 Week Range

Now: $14.60

$10.80

$18.95

Volume

270,828 shs

Average Volume

131,014 shs

Market Capitalization

$211.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Inhibrx?: Inhibrx's top insider shareholders include:
Jon Faiz Kayyem (Director)
Mark Lappe (CEO)
Brendan P Eckelman (Insider)
Global Investors Lp Viking (Major Shareholder)
Kristiina Md Vuori (Director)
Learn More about top insider investors at Inhibrx.